According to research reviewed by Gram, a 2026 study in mice found that the liver enzyme Nat10 is needed to keep liver fat and metabolism in balance. Mice without Nat10 in their livers developed fat buildup and inflammation while eating a normal diet. Whether the same happens in humans is not yet known.
A new study in mice suggests that a liver enzyme called Nat10 plays an important role in keeping the liver’s fat processing and metabolism working normally. Researchers removed Nat10 from the liver cells of mice and found that these animals developed fat buildup in the liver, mild inflammation, and gene activity linked to scarring, even though they ate a normal diet. Mice with extra Nat10 did not show any clear changes. The scientists also found that Nat10 appears to help maintain a gene called Fgf1, which is known to support healthy fat metabolism, and that it may hold back two signaling pathways, Notch and Spp1, that are involved in liver damage. According to research reviewed by Gram, these findings point to a possible new target for understanding fatty liver disease. However, because the work was done in mice, it is too early to say whether the same effects happen in people.
Key Statistics
A 2026 mouse study published in Biochimica et Biophysica Acta found that mice lacking the liver enzyme Nat10 developed fat buildup and inflammation while eating a normal chow diet.
NAT10 is the only known enzyme that adds the ac4C chemical tag to RNA, and a 2026 mouse study linked its loss in the liver to fatty liver changes and a scarring-related gene pattern.
A 2026 study in mice found that adding extra Nat10 to the liver had no detectable effect on liver fat, suggesting the enzyme’s normal levels may be what matter most.
The Quick Take
- What they studied: The researchers wanted to know what job the Nat10 enzyme does in a healthy liver. Scientists already knew it was linked to fatty liver disease and liver scarring during illness, but they did not know its role when the liver is working normally.
- Who participated: The study used laboratory mice. Some mice were bred so that Nat10 was removed only from their liver cells, while others were given extra Nat10 using a harmless virus. The exact number of mice was not listed in the study summary.
- Key finding: Mice without Nat10 in their livers developed fat buildup, inflammation, and a pattern of gene activity linked to scarring, even on a normal diet. Mice given extra Nat10 showed no clear change. The study did not report exact statistical measures in its summary, so the size of these effects is not known from this summary alone.
- What it means for you: This research does not give you anything to do yet. It shows that a liver enzyme may be important for keeping the liver healthy, which could help scientists develop future treatments. Anyone worried about liver fat should talk with a doctor about proven steps such as blood tests and imaging.
The Research Details
The researchers used mice in two main ways. In the first approach, they created mice that lacked Nat10 only in their liver cells. This allowed them to see what happens when the enzyme is missing from the liver while the rest of the body is unchanged. In the second approach, they used a harmless virus to deliver extra Nat10 into the livers of other mice, to see whether more of the enzyme would change anything.
To check the results, the team looked at liver tissue under a microscope and used special dyes to highlight fat. They also measured chemicals in the blood that signal how the liver is functioning. To find out which genes were affected, they studied the genetic material in the liver and tracked a chemical tag that Nat10 adds to RNA, a molecule that helps carry genetic instructions. They then confirmed their most important findings with additional lab tests.
This type of animal study allows scientists to control the environment and change one factor at a time. It is a useful early step, but it cannot tell us exactly how the same process would work in the human body.
Because the researchers could remove Nat10 from only the liver, they could tell that the liver itself was responsible for the changes, not other organs. Testing both loss of the enzyme and extra enzyme also helped show whether the effect was specific to having too little of it. This kind of careful comparison makes the results more believable, even though the study was done in animals.
The study combined several methods, including tissue examination, blood tests, and genetic analysis, which strengthens confidence that the findings are consistent. It was published in a peer-reviewed scientific journal. However, the summary does not state how many mice were used, so readers cannot judge how large the study was. The authors also say some key questions are still unanswered, which is a sign of careful reporting rather than overstated claims.
What the Results Show
The most important result was that mice lacking Nat10 in the liver developed fatty liver changes while still eating a normal chow diet. Fat built up in liver tissue, and the liver showed signs of mild inflammation. These mice were not put on a high-fat diet, which suggests the enzyme plays a role in keeping fat under control even without unhealthy eating.
The team also found a pattern of gene activity in these livers that resembles the early stages of scarring, called fibrosis. Scarring is a concern in long-term liver disease because it can make it harder for the liver to do its job. The changes were seen in the liver, but the study summary does not say how far the scarring progressed.
Using RNA sequencing and a method that maps the chemical tag Nat10 adds, the researchers identified a gene called Fgf1 as a likely target. Fgf1 is already known to help regulate fat metabolism in the liver. The study suggests that Nat10 helps keep Fgf1 working properly, although it does not yet prove that losing Fgf1 is the cause of the fat buildup.
Finally, the researchers found that Nat10 appeared to limit two signaling pathways, Notch and Spp1. When Nat10 was reduced in liver cells grown in the lab, these pathways became more active. Notch and Spp1 are both linked to inflammation and liver damage in other studies. The authors say it is still unclear whether these changes cause the mice’s problems or are simply a side effect.
Mice that received extra Nat10 did not show any detectable changes in liver fat or health. This suggests that having normal levels of the enzyme may be enough for healthy liver function, and that simply adding more may not provide extra benefit. Such results are useful because they show the effect is linked to losing the enzyme rather than to a general boost.
The researchers also confirmed in lab-grown liver cells that adding Nat10 reduced Notch1 and Spp1 activity, while removing it increased them. Because these results match between living animals and cells in a dish, the findings appear to hold up across two different types of experiments.
Earlier research had linked Nat10 to fatty liver disease and liver scarring, but those studies focused mainly on disease conditions. This new study looks at what happens in a normal, healthy liver, which helps explain why the enzyme may matter before disease develops. It also connects Nat10 to Fgf1, a gene already studied for its role in fat metabolism, which adds new detail to how liver fat is controlled.
The most important limitation is that this research was done in mice, and mouse livers do not behave exactly like human livers. The study summary also does not report how many animals were used or the exact statistical results, which makes it harder to judge the strength of each finding. The researchers did not prove that losing Fgf1 or activating Notch and Spp1 directly causes the fatty liver changes. They say these questions still need to be answered. Finally, the study only looked at mice eating a normal diet, so it does not show how Nat10 works under other conditions, such as obesity or long-term heavy drinking.
The Bottom Line
Based on this single animal study, there are no changes that people should make to their diet, exercise, or medical care because of Nat10. The research gives scientists a promising new direction for studying fatty liver disease, but the level of confidence in its relevance to humans is currently low. Further studies in other animals and in people are needed before any practical advice can be given.
Researchers who study liver disease, fat metabolism, and RNA chemistry should find this study useful. People with fatty liver disease, liver scarring, or a family history of liver problems may find it interesting, but it should not change their treatment plans. People without liver concerns do not need to act on these findings at this stage.
Findings from mouse studies often take many years to reach patients, if they reach them at all. Any treatment based on Nat10 would likely need several rounds of animal testing and human clinical trials before it could be used. Most people should expect this work to take a decade or more to affect medical care, if it succeeds.
Frequently Asked Questions
What does the Nat10 enzyme do in the liver?
Nat10 is the only known enzyme that adds the ac4C chemical tag to RNA. A 2026 mouse study suggests it helps keep the liver’s fat metabolism balanced by supporting the Fgf1 gene and limiting Notch and Spp1 signaling. Its full role in people is still unknown.
Can a fatty liver be caused by a missing enzyme?
In a 2026 mouse study, animals without Nat10 in their livers developed fatty liver changes and inflammation even on a normal diet. These results come from animals only. Human fatty liver has many causes, so anyone concerned should speak with a doctor.
Should I take a supplement to boost Nat10 for liver health?
There is no evidence that supplements boost Nat10 in people. In the mouse study, extra Nat10 had no detectable effect on the liver. Proven steps for liver health include limiting alcohol, staying active, and eating mostly whole foods, ideally guided by a healthcare provider.
Has Nat10 research been tested in humans yet?
Not yet. The 2026 study was done in laboratory mice, with some work in liver cells grown in dishes. Scientists would need further animal studies and human clinical trials before knowing whether Nat10 is relevant to human liver disease or treatment.
Want to Apply This Research?
- Encourage users to track measurable liver-related habits they can control, such as weekly alcohol intake, minutes of exercise per week, and daily servings of vegetables. Users with a doctor’s recommendation can also log results from routine liver blood tests, such as ALT and AST, and note the date of each test.
- Users can build habits that support general liver health, which is well supported by existing research. These include limiting alcohol, staying physically active, eating mostly whole foods, and maintaining a healthy weight. The app should clearly state that these habits are known to help the liver, while this new study does not yet change any recommendation.
- Users can review their logged habits and any doctor-ordered lab results every three to six months. Over time, the app can help users notice trends, such as improving activity or changing liver test numbers, and prompt them to discuss results with their healthcare provider. Future research updates on Nat10 can be added as they become available.
This article summarizes a laboratory study in mice and is for general educational purposes only. The findings have not been tested in people and should not be used to diagnose, treat, or prevent any medical condition. Anyone concerned about liver health or fatty liver should consult a qualified healthcare professional before making changes to their diet, supplements, or medical care.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.